GLP-1 News: FDA Approvals, Trial Readouts, Policy Updates

Same-week coverage of GLP-1 FDA approvals, Adcom votes, phase 3 trial readouts, payer-policy changes, and class-action filings. Every post anchored to the primary-source release.

No news posts yet. The next trigger event (FDA approval, Adcom vote, or major trial readout) will be covered here.

In the meantime, browse our trial deep-dives, our Top-N research lists, or our long-form research articles.